Product Information

DIFLUPREDNATE 0.05% EYE DROP is a generic product labeled by Caplin Steriles Limited, priced at $8.0544 per ML under NDC 65145016101. Its NADAC has been published 80 times since May 14, 2025.

FDA first approved this application on Dec 13, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIFLUPREDNATE 0.05% EYE DROP

Difluprednate
$8.0544per ML

Strength

.5 mg/mL

NDC

65145016101

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

DIFLUPREDNATE

Approval Type

Generic (ANDA)

FDA Application

ANDA219441

FDA Approved

12/13/2024

TE Code

AB

On Market Since

12/26/2024

Price Statistics

The NADAC for DIFLUPREDNATE 0.05% EYE DROP has been published 80 times since May 14, 2025, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.0544 per ML
All-time high$13.4452 (May 14, 2025)
All-time low$7.0479 (Jun 17, 2026)
52-week high$10.4599
52-week low$7.0479
Median price$9.8583
Average price$9.8158
Largest weekly change+20.4% (Aug 19, 2026)
Weeks tracked80
Tracking sinceMay 14, 2025

Price History

1W

-11.2%

1M

-16.8%

3M

-9.7%

6M

-0.7%

1Y

-19.8%

3Y

N/A

5Y

N/A

All

-40.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIFLUPREDNATE 0.05% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for DIFLUPREDNATE 0.05% EYE DROP, manufactured by Caplin Steriles Limited, is $8.0544 per ML (NDC 65145016101), effective Nov 18, 2026.

How has the price of DIFLUPREDNATE 0.05% EYE DROP changed over time?

Over the history we have for it, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has declined 40.1%. It has been tracked across 80 weekly CMS publications since May 14, 2025.

What are the highest and lowest recorded NADAC prices for DIFLUPREDNATE 0.05% EYE DROP?

Since May 14, 2025, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has ranged from a low of $7.0479 (Jun 17, 2026) to a high of $13.4452 (May 14, 2025), with a median of $9.8583 per ML.

Are there cheaper alternatives to DIFLUPREDNATE 0.05% EYE DROP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIFLUPREDNATE 0.05% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures DIFLUPREDNATE 0.05% EYE DROP?

DIFLUPREDNATE 0.05% EYE DROP (NDC 65145016101) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.